The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
The gene symbol uap1.S is potentially ambiguous in cross-species searches, and literature is limited for this specific protein. Based on the supplied UniProt/Xenbase record, Q6DCZ6 is the Xenopus laevis short-homeolog/provisional product Uap1-prov, not a UDP-glucose pyrophosphorylase and not a UAP1 protein from another organism. Its UDPGP type-1-family assignment and UDP-sugar-pyrophosphorylase domains are consistent with a UDP-N-acetylglucosamine pyrophosphorylase. However, no publication directly characterizing Q6DCZ6 enzymatically, structurally, genetically, or by cellular imaging was retrieved.
The most defensible primary annotation is therefore an orthology/domain-based prediction: Q6DCZ6 probably catalyzes the terminal reversible reaction of the hexosamine biosynthesis pathway (HBP), UTP + N-acetylglucosamine-1-phosphate ⇌ UDP-N-acetylglucosamine + pyrophosphate, most likely in the cytosol. GlcNAc-1-phosphate is the strongest predicted phosphosugar substrate. Activity toward GalNAc-1-phosphate is plausible from vertebrate UAP1 biology but remains unverified for Q6DCZ6.
| Annotation question | Best-supported conclusion | Evidence type and organism | Confidence and caveat |
|---|---|---|---|
| Exact identity | Q6DCZ6 corresponds to the provisionally named uap1.S / uap1-prov protein of Xenopus laevis. The supplied record assigns it to the UDPGP type-1 family and identifies nucleotide-diphosphosugar transferase, UDP-sugar pyrophosphorylase, UDPGP-family, and PF01704 domains. It should not be confused with UDP-glucose pyrophosphorylase. | User-provided UniProt and Xenbase record-level annotation; published work distinguishes UAP1 from UGP and other nucleotide-sugar pyrophosphorylases (mio1998theeukaryoticudpnacetylglucosamine pages 2-2) | High for record identity; moderate for functional interpretation. The protein description is provisional, and no publication specific to Q6DCZ6 was retrieved. |
| Catalytic reaction | Most likely catalyzes the reversible terminal hexosamine-pathway reaction: UTP + N-acetylglucosamine-1-phosphate ⇌ UDP-N-acetylglucosamine + pyrophosphate. | Orthology and domain inference supported by direct fungal UAP1 biochemistry and established human UAP1 function (paneque2023thehexosaminebiosynthesis pages 9-10, fang2013geneticandstructural pages 1-2, maruyama2007crystalstructureof pages 1-1) | High-confidence inference, not direct frog evidence. Catalytic activity has not been demonstrated experimentally for Q6DCZ6. |
| Substrate specificity | The best-supported predicted substrates are GlcNAc-1-P and UTP. Activity toward GalNAc-1-P is plausible for a vertebrate UAP1-like enzyme but cannot be assigned to Q6DCZ6 without an assay. Human AGX1 is 2–3-fold more active with GalNAc-1-P, whereas AGX2 favors GlcNAc-1-P. | Human isoform biochemistry and fungal substrate-specificity experiments; Aspergillus fumigatus UAP1 selectively uses GlcNAc-1-P (paneque2023thehexosaminebiosynthesis pages 9-10, fang2013geneticandstructural pages 1-2) | High for GlcNAc-1-P as the predicted primary phosphosugar; low-to-moderate for GalNAc-1-P. Human splice-isoform behavior must not be assumed for Q6DCZ6. |
| Catalytic mechanism | Expected to use an induced-fit, divalent-cation-assisted SN2-type uridylyl transfer in which a GlcNAc-1-P phosphate oxygen attacks the UTP α-phosphate. Conserved eukaryotic UAP lysine residues help coordinate phosphate groups. | Direct crystallographic and biochemical evidence from Candida albicans and A. fumigatus UAP1 (raimi2020amechanisminspiredudpnacetylglucosamine pages 1-2, maruyama2007crystalstructureof pages 1-1, maruyama2007crystalstructureof pages 1-2) | Moderate-to-high evolutionary inference. Conservation of the complete catalytic residue set in Q6DCZ6 was not independently verified. |
| Cellular localization | The reaction most likely occurs in the cytosol, generating UDP-GlcNAc for cytosolic and nuclear pathways or subsequent transport into the ER and Golgi. | Vertebrate pathway-topology inference; direct cytoplasmic localization has been reported for rice UAP proteins, not Q6DCZ6 (chen2024hexosaminebiosynthesisand pages 5-6, sosicka2019therapeuticmonosaccharideslooking pages 1-2, wang2021udpnacetylglucosaminepyrophosphorylase2 pages 1-2) | Moderate. No direct microscopy, tagging, or fractionation evidence was found for X. laevis uap1.S. |
| Biochemical pathway | Predicted to perform the fourth and final reaction of the hexosamine biosynthesis pathway, downstream of GFAT, GNPNAT or GNA1, and PGM3 or AGM1. It may also process GlcNAc-1-P derived from salvage metabolism. | Current pathway review and direct UAP1 enzymology in other eukaryotes (raimi2020amechanisminspiredudpnacetylglucosamine pages 1-2, paneque2023thehexosaminebiosynthesis pages 9-10, sosicka2019therapeuticmonosaccharideslooking pages 4-5, paneque2023thehexosaminebiosynthesis pages 1-3) | High-confidence orthology and pathway inference. Frog-specific metabolic-flux evidence is unavailable. |
| Biological processes | By producing UDP-GlcNAc, Q6DCZ6 is predicted to support cytosolic and nuclear O-GlcNAcylation, ER and Golgi N-glycosylation, glycolipid and GPI-anchor synthesis, and glycosaminoglycan production. | Established mammalian and eukaryotic UDP-GlcNAc biology and pathway compartmentation (paneque2023thehexosaminebiosynthesis pages 10-12, paneque2023thehexosaminebiosynthesis pages 1-3, chen2024hexosaminebiosynthesisand pages 5-6) | Moderate-to-high for biochemical contribution; low for frog-specific phenotypes. Product supply does not prove that Q6DCZ6 directly regulates every downstream process. |
| Biological importance | UAP enzymes are essential or strongly required for survival and morphogenesis in several non-vertebrate systems, but essentiality or a developmental role cannot currently be assigned specifically to X. laevis uap1.S. | Direct conditional-genetic evidence in A. fumigatus and loss-and-rescue studies in rice (wang2021udpnacetylglucosaminepyrophosphorylase2 pages 1-2, fang2013geneticandstructural pages 1-2) | Low-to-moderate for extrapolation to Q6DCZ6. Organism-specific biology and possible X. laevis homeolog redundancy limit inference. |
| Applications | No validated application directly targets Q6DCZ6. Fungal UAP1 is under investigation as an antifungal target, and a mechanism-inspired UTP analogue inhibits fungal UAP1 at micromolar concentrations. Broader HBP manipulation is being studied in cancer, immunity, metabolic disease, and glycosylation disorders. | Fungal structural pharmacology and recent pathway reviews (paneque2023thehexosaminebiosynthesis pages 10-12, paneque2023thehexosaminebiosynthesis pages 1-3, raimi2020amechanisminspiredudpnacetylglucosamine pages 1-2) | High that no Q6DCZ6-specific application was identified; moderate for broader translational relevance. Fungal inhibitor and disease-pathway findings are not frog-protein validation. |
Table: Evidence hierarchy for functional annotation of Xenopus laevis uap1.S/Q6DCZ6, separating record-level identity, direct ortholog experiments, and pathway-based inference. Confidence statements identify where frog-specific validation remains absent.
The supplied record identifies:
These attributes are internally consistent with a eukaryotic UAP/UAGPase enzyme. Published cloning work distinguishes UAP1/UDP-GlcNAc pyrophosphorylase from yeast UGP1/UDP-glucose pyrophosphorylase and from other nucleotide-sugar pyrophosphorylases, so the generic family label UDPGP must not be interpreted as proof that Q6DCZ6 primarily makes UDP-glucose (mio1998theeukaryoticudpnacetylglucosamine pages 2-2).
No retrieved paper mentioned Q6DCZ6, X. laevis uap1.S, or uap1-prov. Consequently, the record-level identity can be accepted, but molecular-function details below are principally inferred from conserved domains and experimentally characterized orthologs. Findings for human, fungal, rice, or plant UAP1 are explicitly identified as such and are not presented as direct frog evidence.
The predicted reaction is:
UTP + α-D-GlcNAc-1-phosphate ⇌ UDP-GlcNAc + pyrophosphate (PPi)
This is the fourth and terminal reaction of the canonical eukaryotic HBP. A 2023 review identifies human UAP1, also called GlcNAc-1-phosphate uridyltransferase, as the enzyme catalyzing this reversible conversion (publication: April 2023; https://doi.org/10.3390/genes14040933) (paneque2023thehexosaminebiosynthesis pages 9-10). Direct biochemical assays establish the same forward and reverse reactions for Aspergillus fumigatus UAP1, including direct detection of UDP-GlcNAc depletion and UTP formation during pyrophosphorolysis (publication: July 2013; https://doi.org/10.1111/mmi.12290) (fang2013geneticandstructural pages 1-2).
Accordingly, Q6DCZ6 is best described as a predicted UDP-N-acetylglucosamine pyrophosphorylase/GlcNAc-1-phosphate uridylyltransferase, rather than merely a generic nucleotide-sugar transferase.
High-confidence prediction: UTP is the nucleotide substrate and GlcNAc-1-phosphate is the principal phosphosugar substrate.
The strongest direct specificity evidence comes from fungal UAP1: A. fumigatus AfUAP1 selectively preferred GlcNAc-1-phosphate over alternative sugar phosphates. Its measured Michaelis constants were 34 ± 3 μM for GlcNAc-1-phosphate and 21 ± 2 μM for UTP. UTP inhibited AfUAP1 above 1 mM, with Ki = 1.9 ± 0.2 mM (fang2013geneticandstructural pages 1-2). These values demonstrate the biochemical behavior of a fungal ortholog; they must not be assigned numerically to Q6DCZ6.
Possible secondary activity: Vertebrate UAP1 enzymes can process GalNAc-1-phosphate. Human UAP1 has two splice isoforms, AGX1 and AGX2, differing by a 17-residue insert. AGX1 is reported to be 2–3-fold more active with GalNAc-1-phosphate, whereas AGX2 preferentially processes GlcNAc-1-phosphate (paneque2023thehexosaminebiosynthesis pages 9-10). The supplied frog record does not establish an equivalent splice form or the presence of the determinants responsible for this preference. Thus, UDP-GalNAc production should be annotated only as possible, pending direct testing.
Structural work on Candida albicans UAP1 supports an SN2-type uridylyl-transfer mechanism: a non-esterified oxygen of the GlcNAc-1-phosphate phosphate attacks the α-phosphate of UTP, displacing the β/γ phosphates as PPi. Ligand binding drives induced-fit closure of active-site loops. A conserved lysine coordinates product phosphate groups, while Mg²⁺ promotes catalysis and UTP binding through phosphate coordination (publication: June 2007; https://doi.org/10.1074/jbc.m611873200) (maruyama2007crystalstructureof pages 1-1, maruyama2007crystalstructureof pages 1-2).
More recent A. fumigatus structures captured UDP-GlcNAc, PPi, and Mg²⁺ in a Michaelis-like complex and directly supported pyrophosphorolysis. The conserved fungal Lys437 was proposed to perform a role analogous to a second catalytic metal in bacterial orthologs (publication: March 2020; https://doi.org/10.1039/c9cb00017h) (raimi2020amechanisminspiredudpnacetylglucosamine pages 1-2). Q6DCZ6 probably shares this general fold and mechanism because of its family/domain assignment, but conservation of every catalytic residue was not independently verified here.
In the de novo HBP, glucose-derived fructose-6-phosphate and glutamine enter reactions catalyzed by GFAT, GNA1/GNPNAT, and AGM1/PGM3, producing GlcNAc-1-phosphate. UAP1 then performs terminal uridylylation using UTP. The pathway therefore integrates carbon, nitrogen, acetyl-CoA, and nucleotide availability into UDP-GlcNAc production (raimi2020amechanisminspiredudpnacetylglucosamine pages 1-2, sosicka2019therapeuticmonosaccharideslooking pages 4-5, paneque2023thehexosaminebiosynthesis pages 1-3).
GlcNAc salvage can also supply substrate: NAGK phosphorylates recycled or exogenous GlcNAc to GlcNAc-6-phosphate, and PGM3 converts it to GlcNAc-1-phosphate before the UAP1 reaction. The same predicted Q6DCZ6 activity could therefore service both de novo and salvage-derived flux (paneque2023thehexosaminebiosynthesis pages 10-12, sosicka2019therapeuticmonosaccharideslooking pages 4-5).
The immediate role of Q6DCZ6 is predicted to be metabolite production, not direct signaling. UDP-GlcNAc then acts as a donor or precursor for several systems:
These are downstream uses of the product and should not be interpreted as evidence that Q6DCZ6 directly regulates every associated pathway. Its precise biochemical role is to maintain the relevant UDP-GlcNAc pool.
The most likely site of Q6DCZ6 activity is the cytosol, but confidence is moderate rather than definitive.
Most nucleotide sugars are synthesized in the cytosol, and cytoplasmic UDP-GlcNAc is required directly for O-GlcNAcylation and hyaluronan synthesis. Nucleotide sugars needed in the ER or Golgi are subsequently transported across organelle membranes (sosicka2019therapeuticmonosaccharideslooking pages 1-2). Current pathway topology likewise places initial N-glycan assembly on the cytosolic face of the ER and O-GlcNAc utilization in the cytosol and nucleus, supporting a cytosol-accessible source of UDP-GlcNAc (chen2024hexosaminebiosynthesisand pages 5-6).
Direct cytoplasmic localization has been reported for rice UAP1/UAP2, but that is non-vertebrate evidence and cannot by itself establish frog localization (wang2021udpnacetylglucosaminepyrophosphorylase2 pages 1-2). No fluorescent-tagging, immunolocalization, fractionation, or proteomic localization experiment specific to Q6DCZ6 was found. The appropriate annotation is therefore “predicted cytosolic”, not experimentally verified cytosolic.
No Q6DCZ6-specific knockout, knockdown, overexpression, rescue, or developmental-expression study was retrieved. A frog-specific developmental role therefore cannot presently be assigned.
Across eukaryotes, however, the pathway is often indispensable because UDP-GlcNAc supports multiple forms of glycosylation. Conditional suppression of A. fumigatus uap1 impaired survival, cell-wall synthesis, and morphogenesis (fang2013geneticandstructural pages 1-2). In rice, UAP1 loss causes lesion-mimic spots and early senescence, while UAP2 overexpression rescues the phenotype (wang2021udpnacetylglucosaminepyrophosphorylase2 pages 1-2). These experiments establish the biological importance of UAP enzymes in those organisms, but fungal chitin production and plant leaf survival are not direct models of Xenopus physiology.
For X. laevis, the most conservative expectation is that uap1.S contributes broadly to glycoprotein maturation, intracellular O-GlcNAc signaling, extracellular-matrix glycan production, and membrane-protein biogenesis by supplying UDP-GlcNAc. Whether the .S homeolog is individually essential will depend on expression, dosage, and possible compensation by another X. laevis homeolog; no direct evidence resolving this was found.
The most relevant recent authoritative sources are pathway reviews rather than studies of the frog protein itself.
The expert-level interpretation is that family/domain conservation makes the core Q6DCZ6 enzyme assignment strong, whereas substrate breadth, kinetic constants, expression pattern, homeolog-specific necessity, and localization remain open experimental questions.
There is no validated diagnostic, therapeutic, agricultural, or biotechnology application specific to Q6DCZ6.
The clearest direct UAP1 application is antifungal target discovery. Fungal UAP1 is essential for chitin-supported cell-wall biology, and fungal versus human active-site differences may permit selective inhibition. A mechanism-inspired UTP analogue, meUTP, inhibited A. fumigatus UAP1 at micromolar concentrations, providing a chemical starting point rather than an approved drug (raimi2020amechanisminspiredudpnacetylglucosamine pages 1-2). The biological demand is substantial in fungi: chitin accounts for approximately 1–2% of yeast cell mass and as much as 10–20% of filamentous-fungal dry cell-wall weight (raimi2020amechanisminspiredudpnacetylglucosamine pages 1-2).
Broader HBP manipulation is being investigated in cancer metabolism, immune-cell differentiation, diabetes, glycosylation disorders, and protein homeostasis. For example, GlcNAc salvage supports pancreatic ductal adenocarcinoma under glutamine deprivation, and cell-permeable GlcNAc derivatives can alter N-glycan branching and T-cell differentiation (paneque2023thehexosaminebiosynthesis pages 10-12). These are pathway-level applications; none validates Q6DCZ6 as a drug target or demonstrates a frog implementation.
Recommended primary annotation:
Xenopus laevis uap1.S/Q6DCZ6 is a predicted cytosolic UDP-N-acetylglucosamine pyrophosphorylase (GlcNAc-1-phosphate uridylyltransferase) of the UDPGP type-1 family. It likely catalyzes UTP + GlcNAc-1-phosphate ⇌ UDP-GlcNAc + PPi in the terminal step of de novo and salvage-supported hexosamine biosynthesis, thereby supplying UDP-GlcNAc for intracellular O-GlcNAcylation and secretory-pathway and extracellular-matrix glycosylation.
Confidence by component:
The most informative next steps would be recombinant Q6DCZ6 assays with UTP and a phosphosugar panel—GlcNAc-1-P, GalNAc-1-P, Glc-1-P, Gal-1-P, GlcN-1-P, and GlcNAc-6-P—followed by LC-MS or NMR product confirmation and kinetic determination. Catalytic-site conservation should be checked by sequence/structure alignment against human AGX proteins and fungal UAP1 structures. Endogenous tagging or antibody-based imaging should test cytosolic localization. Finally, homeolog-resolved expression and perturbation in X. laevis embryos would determine whether uap1.S has a unique developmental role or is buffered by another homeolog.
References
(mio1998theeukaryoticudpnacetylglucosamine pages 2-2): T Mio, T Yabe, M Arisawa, and H Yamada-Okabe. The eukaryotic udp-n-acetylglucosamine pyrophosphorylases: gene cloning, protein expression, and catalytic mechanism. Unknown journal, 1998.
(paneque2023thehexosaminebiosynthesis pages 9-10): Alysta Paneque, Harvey Fortus, Julia Zheng, Guy Werlen, and Estela Jacinto. The hexosamine biosynthesis pathway: regulation and function. Apr 2023. URL: https://doi.org/10.3390/genes14040933, doi:10.3390/genes14040933. This article has 276 citations.
(fang2013geneticandstructural pages 1-2): Wenxia Fang, Ting Du, Olawale G. Raimi, Ramon Hurtado‐Guerrero, Michael D. Urbaniak, Adel F. M. Ibrahim, Michael A. J. Ferguson, Cheng Jin, and Daan M. F. van Aalten. Genetic and structural validation of aspergillus fumigatus udp-n-acetylglucosamine pyrophosphorylase as an antifungal target. Molecular Microbiology, 89:479-493, Jul 2013. URL: https://doi.org/10.1111/mmi.12290, doi:10.1111/mmi.12290. This article has 47 citations and is from a domain leading peer-reviewed journal.
(maruyama2007crystalstructureof pages 1-1): Daisuke Maruyama, Yuichi Nishitani, Tsuyoshi Nonaka, Akiko Kita, Takaaki A. Fukami, Toshiyuki Mio, Hisafumi Yamada-Okabe, Toshiko Yamada-Okabe, and Kunio Miki. Crystal structure of uridine-diphospho-n-acetylglucosamine pyrophosphorylase from candida albicans and catalytic reaction mechanism*. Journal of Biological Chemistry, 282:17221-17230, Jun 2007. URL: https://doi.org/10.1074/jbc.m611873200, doi:10.1074/jbc.m611873200. This article has 55 citations and is from a domain leading peer-reviewed journal.
(raimi2020amechanisminspiredudpnacetylglucosamine pages 1-2): Olawale G. Raimi, Ramon Hurtado-Guerrero, Vladimir Borodkin, Andrew Ferenbach, Michael D. Urbaniak, Michael A. J. Ferguson, and Daan M. F. van Aalten. A mechanism-inspired udp-n-acetylglucosamine pyrophosphorylase inhibitor. RSC Chemical Biology, 1:13-25, Mar 2020. URL: https://doi.org/10.1039/c9cb00017h, doi:10.1039/c9cb00017h. This article has 34 citations and is from a peer-reviewed journal.
(maruyama2007crystalstructureof pages 1-2): Daisuke Maruyama, Yuichi Nishitani, Tsuyoshi Nonaka, Akiko Kita, Takaaki A. Fukami, Toshiyuki Mio, Hisafumi Yamada-Okabe, Toshiko Yamada-Okabe, and Kunio Miki. Crystal structure of uridine-diphospho-n-acetylglucosamine pyrophosphorylase from candida albicans and catalytic reaction mechanism*. Journal of Biological Chemistry, 282:17221-17230, Jun 2007. URL: https://doi.org/10.1074/jbc.m611873200, doi:10.1074/jbc.m611873200. This article has 55 citations and is from a domain leading peer-reviewed journal.
(chen2024hexosaminebiosynthesisand pages 5-6): Ya-Huei Chen and Wan-Hsing Cheng. Hexosamine biosynthesis and related pathways, protein n-glycosylation and o-glcnacylation: their interconnection and role in plants. Frontiers in Plant Science, Mar 2024. URL: https://doi.org/10.3389/fpls.2024.1349064, doi:10.3389/fpls.2024.1349064. This article has 29 citations.
(sosicka2019therapeuticmonosaccharideslooking pages 1-2): Paulina Sosicka, Bobby G. Ng, and Hudson H. Freeze. Therapeutic monosaccharides: looking back, moving forward. Biochemistry, 59:3064-3077, Aug 2020. URL: https://doi.org/10.1021/acs.biochem.9b00565, doi:10.1021/acs.biochem.9b00565. This article has 37 citations and is from a peer-reviewed journal.
(wang2021udpnacetylglucosaminepyrophosphorylase2 pages 1-2): Zhaohai Wang, Qiang Wang, Lingxia Wei, Yan Shi, Ting Li, KeKe Hu, Shuai Liu, Hua Zhong, Jianglin Liao, Yangsheng Li, Hongyu Zhang, and Yingjin Huang. Udp-n-acetylglucosamine pyrophosphorylase 2 (uap2) and 1 (uap1) perform synergetic functions for leaf survival in rice. Frontiers in Plant Science, Jun 2021. URL: https://doi.org/10.3389/fpls.2021.685102, doi:10.3389/fpls.2021.685102. This article has 9 citations.
(sosicka2019therapeuticmonosaccharideslooking pages 4-5): Paulina Sosicka, Bobby G. Ng, and Hudson H. Freeze. Therapeutic monosaccharides: looking back, moving forward. Biochemistry, 59:3064-3077, Aug 2020. URL: https://doi.org/10.1021/acs.biochem.9b00565, doi:10.1021/acs.biochem.9b00565. This article has 37 citations and is from a peer-reviewed journal.
(paneque2023thehexosaminebiosynthesis pages 1-3): Alysta Paneque, Harvey Fortus, Julia Zheng, Guy Werlen, and Estela Jacinto. The hexosamine biosynthesis pathway: regulation and function. Apr 2023. URL: https://doi.org/10.3390/genes14040933, doi:10.3390/genes14040933. This article has 276 citations.
(paneque2023thehexosaminebiosynthesis pages 10-12): Alysta Paneque, Harvey Fortus, Julia Zheng, Guy Werlen, and Estela Jacinto. The hexosamine biosynthesis pathway: regulation and function. Apr 2023. URL: https://doi.org/10.3390/genes14040933, doi:10.3390/genes14040933. This article has 276 citations.